Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate.
Chan
F K
FK
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong SAR.
Hawkey
C J
CJ
Lanas
A I
AI
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004381:Duodenal Ulcer / Q000139:chemically induced / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D012306:Risk; D013276:Stomach Ulcer / Q000139:chemically induced / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal